Michael D. West
2013 - BioTime
In 2013, Michael D. West earned a total compensation of $1.6M as Chief Executive Officer at BioTime, a 108% increase compared to previous year.
Compensation breakdown
| Bonus | $65,000 |
|---|---|
| Option Awards | $851,574 |
| Salary | $680,315 |
| Other | $37,750 |
| Total | $1,634,639 |
West received $851.6K in option awards, accounting for 52% of the total pay in 2013.
West also received $65K in bonus, $680.3K in salary and $37.8K in other compensation.
Rankings
In 2013, Michael D. West's compensation ranked 4,599th out of 12,286 executives tracked by ExecPay. In other words, West earned more than 62.6% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 4,599 out of 12,286 | 63rd |
Division Manufacturing | 1,573 out of 4,614 | 66th |
Major group Chemicals And Allied Products | 456 out of 1,466 | 69th |
Industry group Drugs | 318 out of 1,160 | 73rd |
Industry Biological Products, Except Diagnostic Substances | 49 out of 200 | 76th |
Source: SEC filing on June 11, 2015.
West's colleagues
We found four more compensation records of executives who worked with Michael D. West at BioTime in 2013.
News
AgeX Therapeutics CEO Michael West's 2020 pay falls 46% to $561K
November 24, 2021
AgeX Therapeutics CEO Michael West's 2019 pay falls 24% to $1M
November 24, 2020
AgeX Therapeutics CEO Michael West's 2018 pay rises 2% to $1.7M
November 29, 2019
BioTime CEO Brian Culley's 2018 pay jumps 75% to $2.8M
June 14, 2019